Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCC

Clinical trial NCT04174781 · UNKNOWN

Trial details

NCT number: NCT04174781
Sponsor: Zhejiang University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-11-20
Primary completion: 2022-07-30
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.